MX2022013890A - Sintesis y derivados de acido boronico, formas polimorficas y usos terapeuticos de los mismos. - Google Patents

Sintesis y derivados de acido boronico, formas polimorficas y usos terapeuticos de los mismos.

Info

Publication number
MX2022013890A
MX2022013890A MX2022013890A MX2022013890A MX2022013890A MX 2022013890 A MX2022013890 A MX 2022013890A MX 2022013890 A MX2022013890 A MX 2022013890A MX 2022013890 A MX2022013890 A MX 2022013890A MX 2022013890 A MX2022013890 A MX 2022013890A
Authority
MX
Mexico
Prior art keywords
acid derivatives
boronic acid
polymorphic forms
synthesis
therapeutic uses
Prior art date
Application number
MX2022013890A
Other languages
English (en)
Inventor
Yuanqing Fang
Laurent Lefort
Serge Henri Boyer
Scott J Hecker
Matthew M Bio
De Castro Angela Gonzales
Zuolin Zhu
Thomas Linder
Original Assignee
Qpex Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qpex Biopharma Inc filed Critical Qpex Biopharma Inc
Publication of MX2022013890A publication Critical patent/MX2022013890A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/04Esters of boric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44Palladium
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/70Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
    • B01J23/74Iron group metals
    • B01J23/755Nickel
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

En la presente se describen compuestos antimicrobianos, formas polimórficas, composiciones, composiciones farmacéuticas, el método de uso y preparación de los mismos. Algunas modalidades se refieren a derivados de ácido borónico y su uso como agentes terapéuticos, por ejemplo, inhibidores de ß-lactamasa (BLI).
MX2022013890A 2020-05-05 2021-05-04 Sintesis y derivados de acido boronico, formas polimorficas y usos terapeuticos de los mismos. MX2022013890A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063020494P 2020-05-05 2020-05-05
PCT/US2021/030690 WO2021226114A1 (en) 2020-05-05 2021-05-04 Boronic acid derivatives and synthesis, polymorphic forms, and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
MX2022013890A true MX2022013890A (es) 2022-11-30

Family

ID=78468362

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022013890A MX2022013890A (es) 2020-05-05 2021-05-04 Sintesis y derivados de acido boronico, formas polimorficas y usos terapeuticos de los mismos.

Country Status (11)

Country Link
EP (1) EP4149949A4 (es)
JP (1) JP2023524525A (es)
KR (1) KR20230020419A (es)
CN (1) CN115996933A (es)
AU (1) AU2021266715A1 (es)
BR (1) BR112022022367A2 (es)
CA (1) CA3180499A1 (es)
IL (1) IL297458A (es)
MX (1) MX2022013890A (es)
TW (1) TW202207945A (es)
WO (1) WO2021226114A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114539305B (zh) * 2022-02-24 2023-10-31 川北医学院 一种通过对苯并呋喃去芳构化制备双键有机化合物的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3478693T (pt) * 2016-06-30 2021-10-25 Qpex Biopharma Inc Derivados de ácido borónico e suas utilizações terapêuticas
BR112020007138B1 (pt) * 2017-10-11 2023-03-21 Qpex Biopharma, Inc Derivados de ácido borônico, métodos de síntese, composição farmacêutica e uso dos mesmos

Also Published As

Publication number Publication date
AU2021266715A1 (en) 2022-11-17
IL297458A (en) 2022-12-01
WO2021226114A1 (en) 2021-11-11
TW202207945A (zh) 2022-03-01
BR112022022367A2 (pt) 2023-01-10
KR20230020419A (ko) 2023-02-10
EP4149949A1 (en) 2023-03-22
JP2023524525A (ja) 2023-06-12
CA3180499A1 (en) 2021-11-11
CN115996933A (zh) 2023-04-21
EP4149949A4 (en) 2024-05-15

Similar Documents

Publication Publication Date Title
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
MX2021000925A (es) Inhibidores de inflamasoma nlrp3.
CR20230310A (es) Inhibidores de prmt5
MX2022006475A (es) Compuestos triciclicos sustituidos.
MX2021005463A (es) Derivados de espiro-sulfonamida como inhibidores de la proteina de leucemia de celula mieloide 1 (mcl-1).
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
EA201101671A1 (ru) Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина
PH12019550140A1 (en) Piperidine-substituted mnk inhibitors and methods related thereto
MX2023003264A (es) Inhibidores de cdk y su uso como productos fármaceuticos.
SA520411787B1 (ar) مشتقات بنزيميدازول واستخداماتها
MX2022001789A (es) Derivados de 2-hidroxicicloalcan-1-carbamoilo.
MX2023007265A (es) Inhibidores de cdk y su uso como productos farmacéuticos.
MX2012015100A (es) Compuestos y composiciones de heteroarilo como inhibidores de cinasa de proteina.
MX2022013273A (es) Compuestos y composiciones para inhibir la actividad de hif2-alfa y sus metodos de uso.
MX2022007171A (es) Compuestos cíclicos y métodos de uso de estos.
SA522441965B1 (ar) Trpa1 مشتقات تترازول كمثبطات لـ
MY195576A (en) Novel Amino-Imidazopyridine Derivatives as Janus Kinase Inhibitors and Pharmaceutical use Thereof
SA522431777B1 (ar) مشتقات ألفا -d- جالاكتو بيرانوسيد
MX2023011829A (es) Derivados de uracilo como inhibidores de trpa1.
ZA202310682B (en) Nicotinamide ripk1 inhibitors
MX2023000198A (es) Inhibidores de atr y usos de estos.
MX2022013890A (es) Sintesis y derivados de acido boronico, formas polimorficas y usos terapeuticos de los mismos.
SA522441973B1 (ar) Trpa1 مشتقات تترازول كمثبطات لـ
WO2023049808A3 (en) Small molecule inhibitors of tead-yap
MX2023012468A (es) Compuestos como inhibidores de pd1/pd-l1 y metodos de los mismos.